Press release from Companies
Published: 2025-11-06 10:01:00
Med-tech company PolarCool AB (publ.) announces that the England Men’s Rugby League Team will provide concussion treatment with PolarCap® during the ongoing Ashes Series against Australia.
The England men’s national rugby league team will evaluate PolarCap® for the acute management of concussions during the ongoing Ashes Series, taking place this autumn (2025). The first two matches of the series was played over the last two weekends, with both teams providing the treatment. Having England and Australia’s national rugby league teams providing PolarCap® throughout the series, marks an important step for PolarCool in the global expansion of PolarCap® across elite rugby league.
England is one of PolarCool’s most established European markets, with the company already collaborating with several professional clubs and organizations across the UK. The addition of the English national team further strengthens PolarCool’s position in rugby league and reinforces the interest for evidence-based treatment solutions.
PolarCool CEO Erik Andersson comments:
-We are honoured that both England and Australia’s national rugby league teams are both providing PolarCap® during this historic series. The fact that both national teams have chosen to provide PolarCap® demonstrates the desire and importance of player safety and establishing evidence-based treatments that protect players.
For more information
Erik Andersson – CEO PolarCool AB (publ.)
+46 - 738 60 57 00
E-mail: erik.andersson@polarcool.se
About PolarCool AB (publ.)
PolarCool AB (publ.) is a Swedish medical technology company focused on developing and marketing products in the sports medicine field. Its primary product, PolarCap®, is designed to reduce the impact of concussion through targeted brain cooling. PolarCool works with professional teams across Europe in rugby, football, and ice hockey and it shares are listed on Spotlight Stock Market.